Advanced Filter

Filter by Group

Filter by Market Availability

Clear
Displaying drugs 14726 - 14750 of 14852 in total

2,5-dibenzyloxy-3-hydroxy-hexanedioic acid bis-[(2-hydroxy-indan-1-yl)-amide]

Experimental

IMIDAZOPYRIDAZIN 1

Experimental

9-DEAZAINOSINE-2',3'-O-ETHYLIDENEPHOSPHONATE

Experimental

L-1-naphthyl-2-acetamido-ethane boronic acid

Experimental

1-((2-HYDROXYETHOXY)METHYL)-5-(3-(BENZYLOXY)BENZYL)-6-HYDROXYPYRIMIDINE-2,4(1H,3H)-DIONE

Experimental

6-HYDROXY-1,3-BENZOTHIAZOLE-2-SULFONAMIDE

Experimental

GSI-136

GSI-136 has been used in trials studying the treatment of Alzheimer Disease.
Investigational

ING-1

ING-1 is a high-affinity, human engineered trade mark monoclonal antibody that recognizes a 40 kilodalton epithelial cell adhesion molecule (EpCAM) glycoprotein that is expressed in high levels on most adenocarcinomas. It is an attractive target for immunotherapy.
Investigational

Amitifadine

Investigational

Fluoresceinylthioureido

Experimental

FR230513

Experimental

2',3'-dideoxy-3'-fluoro-urididine-5'-diphosphate

Experimental

Patidegib

Patidegib has been investigated for the treatment of Conventional Chondrosarcoma.
Investigational

Doramapimod

Doramapimod is a P38 MAP kinase inhibitor.
Investigational

2-(3'-Methoxyphenyl) Benzimidazole-4-Carboxamide

Experimental

Zanapezil

Zanapezil (TAK-147) is a selective acetylcholine (ACh) esterase inhibitor under investigation as a drug for Alzheimer's disease (AD) treatment.
Investigational

(2R,3R)-7-(methylsulfonyl)-3-(2,4,5-trifluorophenyl)-1,2,3,4-tetrahydropyrido[1,2-a]benzimidazol-2-amine

Experimental

4-(2-HYDROXY-4-FLUOROPHENYLTHIO)-BUTYLPHOSPHONIC ACID

Experimental

(3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE

Experimental

[4-amino-2-(tert-butylamino)-1,3-thiazol-5-yl](phenyl)methanone

Experimental

Albaconazole

Albaconazole has been used in trials studying the basic science of Onychomycosis.
Investigational

Oxyfedrine

Experimental

Methoxyamine

Investigational

R450

R450 is an alpha 1 antagonist that acts to tighten the muscle tone in the bladder. It is being considered for treatment of stress-related urinary incontinence. Phase IIa data for the drug show it reduced the number of incontinent episodes compared to placebo with minimal cardiovascular effects.
Investigational

AMG-222

Investigational
Displaying drugs 14726 - 14750 of 14852 in total